Raghwa Sharma Selected Research

Drug Therapy (Chemotherapy)

1/2018	Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study.
1/2017	EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas.
11/2008	Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raghwa Sharma Research Topics

Disease

13	Neoplasms (Cancer) 11/2023 - 07/2004
8	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 11/2008
7	Carcinoma (Carcinomatosis) 01/2023 - 12/2014
6	Melanoma (Melanoma, Malignant) 01/2016 - 07/2004
3	Ovarian Epithelial Carcinoma 11/2023 - 03/2011
3	Neoplasm Metastasis (Metastasis) 12/2012 - 08/2004
2	Inflammation (Inflammations) 11/2011 - 03/2011
1	Endometriosis 01/2022
1	Teratoma (Teratoid Tumor) 01/2022
1	Turcot syndrome 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2017
1	Colitis 01/2016
1	Acute Generalized Exanthematous Pustulosis 01/2016
1	Infections 06/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2015
1	Carcinogenesis 12/2012
1	Memory Disorders (Memory Loss) 09/2012
1	Brain Diseases (Brain Disorder) 09/2012
1	Nervous System Diseases (Neurological Disorders) 09/2012
1	Psychotic Disorders (Schizoaffective Disorder) 09/2012
1	Encephalitis (Encephalitis, Rasmussen) 09/2012
1	Seizures (Absence Seizure) 09/2012
1	Fibrosis (Cirrhosis) 11/2011
1	Arthritis (Polyarthritis) 11/2011
1	Cysts 03/2011
1	Adenocarcinoma 11/2008
1	Neoplasm Micrometastasis 07/2004

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2013
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2023
2	Peptides (Polypeptides)IBA 01/2020 - 11/2011
2	Capsules (Microcapsules)IBA 10/2004 - 07/2004
1	CyclinsIBA 01/2023
1	ParaffinIBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	ChromatinIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	TransducinIBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	Retinoblastoma ProteinIBA 01/2018
1	taxaneIBA 01/2018
1	Papillomavirus Vaccines (HPV Vaccines)IBA 10/2017
1	IpilimumabIBA 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Phosphotransferases (Kinase)IBA 06/2015
1	Indicators and Reagents (Reagents)IBA 12/2014
1	VemurafenibIBA 12/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2012
1	DNA (Deoxyribonucleic Acid)IBA 12/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2011
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2011
1	Hormones (Hormone)IBA 03/2011
1	Epithelial Cell Adhesion MoleculeIBA 03/2011
1	Cisplatin (Platino)FDA LinkGeneric 11/2008
1	PlatinumIBA 11/2008
1	Small Interfering RNA (siRNA)IBA 11/2008
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2004
1	S100 Proteins (S 100 Protein)IBA 08/2004
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2004

Therapy/Procedure

4	Therapeutics 01/2022 - 07/2004
3	Drug Therapy (Chemotherapy) 01/2018 - 11/2008
3	Lymph Node Excision (Lymph Node Dissection) 10/2004 - 07/2004
1	Adjuvant Chemotherapy 01/2022
1	Lasers (Laser) 10/2017
1	Precision Medicine 12/2012
1	Intra-Articular Injections 11/2011